PAPGENE, INC.
BALTIMORE, MD · Founded 2014 · CIK 0001634570 · Medtech · Acquired
PapGene: a genetic sequencing-based cytology test that detects ovarian and endometrial cancer from Pap specimens by identifying cancer-causing DNA mutations
- Grants
- $4.1M
- 3 awards
- Sector median: 1
- Raised
- $3.0M
- 1 Form D · Feb 2015
- 140 months since last filing
- Contracts
- $1.5M
- 1 award · Health and Human S
- #264 of 4531 in medtech
- Patents
- —
- No published records under this name
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20142015201620172018
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $3,000,089 | |
| Federal grant | Department of Health and Human Services · Phase I · Genetic Cytology for Ovarian and Endometrial Cancer Screening | $1,286,663 | |
| Federal contract | Department of Health and Human Services · Igf::ot::igf Genetic Cytology For Surveillance Of Recurrent Bladder Cancer | $1,490,821 | |
| Federal grant | Department of Health and Human Services · Phase II · Genetic Cytology for Ovarian and Endometrial Cancer Screening | $910,751 |
Federal grant · SBIR/STTRFederal contract · USAspendingForm D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 261 | CIENCIA INC | $1.5M | — |
| 262 | FOOTHOLD LABS INC | $1.5M | $4K |
| 263 | YOUV LABS | $1.5M | — |
| 264 | PAPGENE, INC. | $1.5M | $3.0M |
| 265 | NEOCIS INC | $1.5M | $119M |
| 266 | JSL Innovations LLC | $1.5M | — |
| 267 | APPLIED BIOPHYSICS, INC. | $1.4M | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- HOWARD KAUFMANExecutive Officer
- ISAAC KINDEExecutive Officer
- KENNETH KINZLERDirector · Executive Officer
- NICK PAPADOPOULOSDirector · Executive Officer
- SHIBIN ZHOUDirector · Executive Officer
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.